Microorganism |
|
|
|
Antimicrobial |
|
|
Reference |
Streptococcus spp. (Viridans group) |
0.016 |
0.12 |
≤0.008 - 2 |
Imipenem |
493 |
Streptococcus spp. (Viridans group) |
0.03 |
0.03 |
0.008 - 0.06 |
PD 0305970 |
225 |
Streptococcus spp. (Viridans group) |
0.03 |
0.06 |
0.015 - 0.06 |
PD 0326448 |
225 |
Streptococcus spp. (Viridans group) |
0.03 |
0.12 |
0.008 - 0.5 |
Tigecycline (GAR-936, Tigacyl) |
462 |
Streptococcus spp. (Viridans group) |
0.03 |
0.25 |
≤0.03 - 8 |
Amoxicillin-clavulanate |
493 |
Streptococcus spp. (Viridans group) |
>0.03 |
>4 |
≤0.03 - >4 |
Erythromycin (E-mycin, Ery-tab, Benzamycin) |
462 |
Streptococcus spp. (Viridans group) |
0.03 |
- |
0.015 - 4 |
Erythromycin (E-mycin, Ery-tab, Benzamycin) |
248 |
Streptococcus spp. (Viridans group) |
0.06 |
0.12 |
? - ? |
Clinafloxacin (PD 127391) |
307 |
Streptococcus spp. (Viridans group) |
0.06 |
1 |
≤0.015 - >2 |
Ceftriaxone (Rocephin) |
462 |
Streptococcus spp. (Viridans group) |
0.06 |
- |
0.008 - 2 |
Imipenem |
248 |
Streptococcus spp. (Viridans group) |
0.06 |
- |
0.03 - 1 |
Penicillin (Benzylpenicillin, Penicillin G, Bicillin C-R/L-A, Pfizerpen, Wycellin) |
248 |
Streptococcus spp. (Viridans group) |
0.06 |
- |
0.06 - 0.125 |
Clinafloxacin (PD 127391) |
248 |
Streptococcus spp. (Viridans group) |
0.06 |
- |
0.06 - 0.125 |
PD 124816 |
248 |
Streptococcus spp. (Viridans group) |
≤0.12 |
≤0.12 |
≤0.12 - 0.5 |
Telithromycin (HMR 3647, RU-66647, Ketek) |
18 |
Streptococcus spp. (Viridans group) |
0.12 |
0.25 |
0.03 - 0.25 |
Cefdinir (Omnicef, Cefdiel) |
267 |
Streptococcus spp. (Viridans group) |
0.12 |
0.25 |
0.03 - 2 |
Imipenem |
102 |
Streptococcus spp. (Viridans group) |
0.12 |
0.25 |
0.06 - 0.25 |
Garenoxacin (T-3811, BMS-284756) |
102 |
Streptococcus spp. (Viridans group) |
0.12 |
0.5 |
≤0.008 - 4 |
Ertapenem (Invanz) |
493 |
Streptococcus spp. (Viridans group) |
0.12 |
0.5 |
0.06 - >2 |
Trovafloxacin (Trovan) |
462 |
Streptococcus spp. (Viridans group) |
0.12 |
1 |
≤0.03 - >4 |
Penicillin (Benzylpenicillin, Penicillin G, Bicillin C-R/L-A, Pfizerpen, Wycellin) |
462 |
Streptococcus spp. (Viridans group) |
0.12 |
4 |
≤0.06 - >8 |
Amoxicillin-clavulanic acid (Augmentin) |
462 |
Streptococcus spp. (Viridans group) |
0.12 |
8 |
≤0.12 - >16 |
Clindamycin (Cleocin) |
18 |
Streptococcus spp. (Viridans group) |
0.125 |
0.25 |
0.06 - 0.25 |
Garenoxacin (T-3811, BMS-284756) |
225 |
Streptococcus spp. (Viridans group) |
0.125 |
- |
0.06 - 0.25 |
Difluoroquinolone (PD 117596) |
248 |
Streptococcus spp. (Viridans group) |
0.25 |
0.25 |
0.12 - 0.5 |
Moxifloxacin (BAY 12-8039, Avelox) |
102 |
Streptococcus spp. (Viridans group) |
0.25 |
0.5 |
0.06 - 0.5 |
Gatifloxacin (Tequin) |
102 |
Streptococcus spp. (Viridans group) |
0.25 |
1 |
0.015 - >32 |
Ceftriaxone (Rocephin) |
102 |
Streptococcus spp. (Viridans group) |
0.25 |
1 |
0.03 - 4 |
Amoxicillin-clavulanic acid (Augmentin) |
102 |